Evidence map›Paper›PMID 41595656›Full record

ArticleBiomedicines2026

MicroRNAs as Key Regulators in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Bioinformatics Analysis.

Claudriana Locatelli, Karine Luz, Sergio Fallone de Andrade, Emyr Hiago Bellaver, Rosana Claudio Silva Ogoshi, Ariana Centa, João Paulo Assolini, Gustavo Colombo Dal Pont, Tania Beatriz Creczynski-Pasa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claudriana LocatelliGraduate Program in Development and Society, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0003-4708-6641
Karine LuzGraduate Program in Development and Society, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0002-2983-387X
Sergio Fallone de AndradeResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0001-9294-7290
Emyr Hiago BellaverCenter for Health Science, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0002-7169-1000
Rosana Claudio Silva OgoshiGraduate Program in Development and Society, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0003-4383-8236
Ariana CentaGraduate Program in Development and Society, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0002-0419-141X
João Paulo AssoliniGraduate Program in Development and Society, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0003-4190-8835
Gustavo Colombo Dal PontGraduate Program in Development and Society, Alto Vale do Rio do Peixe University, Caçador 89500-199, Santa Catarina, Brazil.ORCID 0000-0003-2164-9653
Tania Beatriz Creczynski-PasaDepartment of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-900, Santa Catarina, Brazil.ORCID 0000-0002-6026-2948

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

epigenetichepatic inflammationinsulin resistanceliver fibrosismicroRNA-122microRNA-29amiRNA target predictionregulation

Identifiers

PMID41595656
PMCPMC12838594

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.